Cornerstone Advisors (Washington)’s Integra LifeSciences IART Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$10K	Buy	208 +18	+9%	+$856	﹤0.01%	434
2020 Q2	$9K	Buy	190 +139	+273%	+$6.83K	﹤0.01%	440
2020 Q1	$2K	Buy	+51	New	+$2.68K	﹤0.01%	589
2019 Q2	–	Sell	-22	Closed	-$1K	–	1514
2019 Q1	$1K	Buy	22 +4	+22%	+$204	﹤0.01%	1182
2018 Q4	$1K	Hold	18	–	–	﹤0.01%	1000
2018 Q3	$1K	Hold	18	–	–	﹤0.01%	1022
2018 Q2	$1K	Hold	18	–	–	﹤0.01%	1000
2018 Q1	$1K	Buy	+18	New	+$943	﹤0.01%	982

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Cornerstone Advisors (Washington)'s IART Position: Q3 2020 in Review

Cornerstone Advisors (Washington) increased its Integra LifeSciences (IART) stake by 9.5% in Q3 2020, buying an estimated $856 and bringing the position to 208 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #434.

Cornerstone Advisors (Washington) first reported a position in IART in Q1 2018 and has held it in 8 quarters since. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

Cornerstone Advisors (Washington) held 208 shares of Integra LifeSciences worth $10K as of Q3 2020.
Cornerstone Advisors (Washington) bought 18 Integra LifeSciences shares in Q3 2020, an estimated $856.
Integra LifeSciences made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #434 holding.
Cornerstone Advisors (Washington) first reported a position in Integra LifeSciences in Q1 2018 and has held it in 8 quarters since.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.